Title: Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist.
Journal: The Journal of physiology 20140815
Title: Ectopic uterine tissue as a chronic pain generator.
Journal: Neuroscience 20121206
Title: Reversal of BoNT/A-mediated inhibition of muscle paralysis by 3,4-diaminopyridine and roscovitine in mouse phrenic nerve-hemidiaphragm preparations.
Journal: Neurochemistry international 20121101
Title: Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.
Journal: American journal of human genetics 20120713
Title: The safety profile of dalfampridine extended release in multiple sclerosis clinical trials.
Journal: Clinical therapeutics 20120501
Title: 3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis.
Journal: Journal of neuroimmunology 20120401
Title: Recurrent COLQ mutation in congenital myasthenic syndrome.
Journal: Pediatric neurology 20120401
Title: The dynamic relationships between the three events that release individual Na⁺ ions from the Na⁺/K⁺-ATPase.
Journal: Nature communications 20120214
Title: Content variability of active drug substance in compounded oral 3,4-diaminopyridine products.
Journal: Journal of clinical pharmacy and therapeutics 20120201
Title: Clinical features in a series of fast channel congenital myasthenia syndrome.
Journal: Neuromuscular disorders : NMD 20120201
Title: Long-term disease history, clinical symptoms, health status, and healthcare utilization in patients suffering from Lambert Eaton myasthenic syndrome: Results of a patient interview survey in Germany.
Journal: Journal of medical economics 20120101
Title: Hypotension due to Chemotherapy in a Patient with Small Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome Undergoing Hemodialysis: A First Case Report.
Journal: Case reports in oncology 20120101
Title: Nervous System of Periplaneta americana Cockroach as a Model in Toxinological Studies: A Short Historical and Actual View.
Journal: Journal of toxicology 20120101
Title: The use of aminopyridines in neurological disorders.
Journal: Clinical neuropharmacology 20120101
Title: The Effects of K(+) Channel Blockade on Eccentric and Isotonic Twitch and Fatiguing Contractions in situ.
Journal: Frontiers in physiology 20120101
Title: [Aminopyridines for symptomatic treatment of multiple sclerosis].
Journal: Ugeskrift for laeger 20111212
Title: Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20111201
Title: John Newsom-Davis: clinician-scientist and so much more.
Journal: Brain : a journal of neurology 20111201
Title: Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology.
Journal: Neurology 20111108
Title: Formulating a new basis for the treatment against botulinum neurotoxin intoxication: 3,4-Diaminopyridine prodrug design and characterization.
Journal: Bioorganic & medicinal chemistry 20111101
Title: One collective case of type A foodborne botulism in Corsica.
Journal: Clinical toxicology (Philadelphia, Pa.) 20111001
Title: Role of calcium-activated potassium channels in the genesis of 3,4-diaminopyridine-induced periodic contractions in isolated canine coronary artery smooth muscles.
Journal: The Journal of pharmacology and experimental therapeutics 20110901
Title: Autoimmune neuromuscular disorders.
Journal: Current neuropharmacology 20110901
Title: Autoimmune channelopathies of the nervous system.
Journal: Current neuropharmacology 20110901
Title: Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20110817
Title: Single-pixel optical fluctuation analysis of calcium channel function in active zones of motor nerve terminals.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20110803
Title: Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations.
Journal: Muscle & nerve 20110801
Title: Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus.
Journal: Journal of neurology 20110701
Title: Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea.
Journal: PLoS neglected tropical diseases 20110501
Title: Medical treatment for botulism.
Journal: The Cochrane database of systematic reviews 20110316
Title: Effects of 3-4 diaminopyridine (DAP) in motor neuron diseases.
Journal: Journal of clinical neuromuscular disease 20110301
Title: Treatment for Lambert-Eaton myasthenic syndrome.
Journal: The Cochrane database of systematic reviews 20110216
Title: A Cys-loop mutation in the Caenorhabditis elegans nicotinic receptor subunit UNC-63 impairs but does not abolish channel function.
Journal: The Journal of biological chemistry 20110128
Title: Protein kinases modulate store-operated channels in pulmonary artery smooth muscle cells.
Journal: Journal of biomedical science 20110101
Title: Suramin inhibits the early effects of PLA(2) neurotoxins at mouse neuromuscular junctions: A twitch tension study.
Journal: Journal of venom research 20110101
Title: Pricing and reimbursement of orphan drugs: the need for more transparency.
Journal: Orphanet journal of rare diseases 20110101
Title: Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine.
Journal: Neuropsychiatric disease and treatment 20110101
Title: The neuromuscular activity of Micrurus pyrrhocryptus venom and its neutralization by commercial and specific coral snake antivenoms.
Journal: Journal of venom research 20110101
Title: Cerebellum and ocular motor control.
Journal: Frontiers in neurology 20110101
Title: Lambert-eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy.
Journal: Autoimmune diseases 20110101
Title: Symptomatic relief of botulinum neurotoxin/a intoxication with aminopyridines: a new twist on an old molecule.
Journal: ACS chemical biology 20101217
Title: Orphan drugs. BioMarin Europe replies.
Journal: BMJ (Clinical research ed.) 20101207
Title: Orphan drugs. Regulation is flawed.
Journal: BMJ (Clinical research ed.) 20101207
Title: 3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome.
Journal: Expert review of clinical immunology 20101101
Title: 3,4-Diaminopyridinium 2-carboxy-4,6-dinitrophenolate.
Journal: Acta crystallographica. Section E, Structure reports online 20101101
Title: State of the art in hereditary muscle channelopathies.
Journal: Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 20101001
Title: Anharmonic vibrational analysis of 3,4-diaminopyridine and 3-aminopyridine by density functional theory calculations.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20100901
Title: The price you pay.
Journal: Drug and therapeutics bulletin 20100901
Title: 3-D-QSAR and docking studies on the neuronal choline transporter.
Journal: Bioorganic & medicinal chemistry letters 20100815
Title: Guidelines for treatment of autoimmune neuromuscular transmission disorders.
Journal: European journal of neurology 20100701
Title: Lambert-Eaton myasthenic syndrome as a cause of persistent neuromuscular weakness after a mediastinoscopic biopsy -A case report-.
Journal: Korean journal of anesthesiology 20100701
Title: Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.
Journal: Human molecular genetics 20100615
Title: 3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.
Journal: Journal of neurology 20100601
Title: Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions.
Journal: Neuropharmacology 20100601
Title: Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment.
Journal: Current medical research and opinion 20100601
Title: The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
Journal: Journal of the neurological sciences 20100515
Title: Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
Journal: Neurology 20100511
Title: The zinc-dependent protease activity of the botulinum neurotoxins.
Journal: Toxins 20100501
Title: [Lambert-Eaton myasthenic syndrome (LEMS)].
Journal: Brain and nerve = Shinkei kenkyu no shinpo 20100401
Title: Neuropharmacology of vestibular system disorders.
Journal: Current neuropharmacology 20100301
Title: 4-Amino-3-ammonio-pyridinium dinitrate.
Journal: Acta crystallographica. Section E, Structure reports online 20100301
Title: Quantification of 4-aminopyridine in plasma by capillary electrophoresis with electrokinetic injection.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100201
Title: Effect of pantoprazole and its interactions with vecuronium on the neuromuscular junction.
Journal: Indian journal of pharmacology 20100201
Title: Improvement of diaphragm and limb muscle isotonic contractile performance by K+ channel blockade.
Journal: Journal of neuroengineering and rehabilitation 20100101
Title: [Lambert-Eaton myasthenic syndrome associated with pulmonary squamous cell carcinoma and circulating anti-P/Q-type voltage-gated calcium channel antibody].
Journal: Rinsho shinkeigaku = Clinical neurology 20100101
Title: New methods for diagnosis and treatment of vestibular diseases.
Journal: F1000 medicine reports 20100101
Title: Eye disorders in patients with multiple sclerosis: natural history and management.
Journal: Clinical ophthalmology (Auckland, N.Z.) 20100101
Title: Sensing the deadliest toxin: technologies for botulinum neurotoxin detection.
Journal: Toxins 20100101
Title: Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties.
Journal: Nanotechnology 20091111
Title: 3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS.
Journal: Muscle & nerve 20091101
Title: {2,2'-[Pyridine-3,4-diylbis(nitrilo-methyl-idyne)]diphenolato}zinc(II).
Journal: Acta crystallographica. Section E, Structure reports online 20091101
Title: Management of myasthenic conditions: nonimmune issues.
Journal: Current opinion in neurology 20091001
Title: 3,4-Diamino-pyridinium 4-nitro-benzoate-4-nitro-benzoic acid (1/1).
Journal: Acta crystallographica. Section E, Structure reports online 20090801
Title: Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study.
Journal: Clinical pharmacology and therapeutics 20090701
Title: Skeletal muscle contraction-induced vasodilator complement production is dependent on stimulus and contraction frequency.
Journal: American journal of physiology. Heart and circulatory physiology 20090701
Title: 3,4-Diamino-pyridinium hydrogen succinate.
Journal: Acta crystallographica. Section E, Structure reports online 20090701
Title: Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome.
Journal: Journal of medical genetics 20090301
Title: [Treatment approach to congenital myasthenic syndrome in a patient with acetylcholine receptor deficiency].
Journal: No to hattatsu = Brain and development 20090101
Title: [A case of Lambert-Eaton myasthenic syndrome with small cell lung cancer, treated with 3,4-diaminopyridine].
Journal: Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090101
Title: 4-Amino-3-ammonio-pyridinium dichloride.
Journal: Acta crystallographica. Section E, Structure reports online 20090101
Title: [Pharmacotherapy of central oculomotor disorders].
Journal: Der Nervenarzt 20081201
Title: Long-lasting in vivo inotropic effects of the K(+) channel blocker 3,4-diaminopyridine during fatigue-inducing stimulation.
Journal: Muscle & nerve 20081201
Title: Therapeutic strategies in congenital myasthenic syndromes.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20081001
Title: Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Journal: Journal of neuroimmunology 20080915
Title: Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression.
Journal: Brain structure & function 20080901
Title: Mechanisms of neuromodulation as dissected using Sr2+ at motor nerve endings.
Journal: Journal of neurophysiology 20080601
Title: Onset dynamics of type A botulinum neurotoxin-induced paralysis.
Journal: Journal of pharmacokinetics and pharmacodynamics 20080601
Title: Inotropic effects of the K+ channel blocker 3,4-diaminopyridine on fatigued diaphragm muscle.
Journal: Respiratory physiology & neurobiology 20080101
Title: [Lambert-Eaton Myasthenic Syndrome associated with vocal cord carcinoma].
Journal: Revue neurologique 20080101
Title: L-type Ca2+ channel function is linked to dystrophin expression in mammalian muscle.
Journal: PloS one 20080101
Title: Autoantibodies in neuromuscular transmission disorders.
Journal: Annals of Indian Academy of Neurology 20080101
Title: [Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine].
Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20070810
Title: Beneficial effects of 3,4-diaminopyridine on positioning downbeat nystagmus in a circumscribed uvulo-nodular lesion.
Journal: Journal of neurology 20070801
Title: Childhood myasthenia: clinical subtypes and practical management.
Journal: Developmental medicine and child neurology 20070801
Title: Myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient.
Journal: Muscle & nerve 20070701
Title: Potassium initiates vasodilatation induced by a single skeletal muscle contraction in hamster cremaster muscle.
Journal: The Journal of physiology 20070601
Title: Molecular docking study of the binding of aminopyridines within the K+ channel.
Journal: Journal of molecular modeling 20070501
Title: Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
Journal: The European journal of neuroscience 20070501
Title: The therapy of congenital myasthenic syndromes.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20070401
Title: Stability studies of ionised and non-ionised 3,4-diaminopyridine: hypothesis of degradation pathways and chemical structure of degradation products.
Journal: Journal of pharmaceutical and biomedical analysis 20070104
Title: [Treatment of Lambert-Eaton syndrome with 3,4- diaminopyridine and pyridostigmine].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20070101
Title: Inotropic effects of the K+ channel blocker 3,4-diaminopyridine: differential responses of rat soleus and extensor digitorum longus.
Journal: IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 20061201
Title: Altered diaphragm muscle action potentials in Zucker diabetic fatty (ZDF) rats.
Journal: Respiratory physiology & neurobiology 20060928
Title: Treatment of the gravity dependence of downbeat nystagmus with 3,4-diaminopyridine.
Journal: Neurology 20060912
Title: Extrusion of Ca2+ from mouse motor terminal mitochondria via a Na+-Ca2+ exchanger increases post-tetanic evoked release.
Journal: The Journal of physiology 20060801
Title: Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'.
Journal: Brain : a journal of neurology 20060801
Title: Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment.
Journal: Pharmacology & therapeutics 20060701
Title: Available treatment options for the management of Lambert-Eaton myasthenic syndrome.
Journal: Expert opinion on pharmacotherapy 20060701
Title: Guidelines for the treatment of autoimmune neuromuscular transmission disorders.
Journal: European journal of neurology 20060701
Title: No benefit of 3,4-diaminopyridine in essential tremor: a placebo-controlled crossover study.
Journal: Neurology 20060613
Title: The effects of presynaptic calcium channel modulation by roscovitine on transmitter release at the adult frog neuromuscular junction.
Journal: The European journal of neuroscience 20060601
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Fetal exposure to 3,4-diaminopyridine in a pregnant woman with congenital myasthenia syndrome.
Journal: The Annals of pharmacotherapy 20060401
Title: [Fatigue and episodic exhaustion as a feature of multiple sclerosis].
Journal: Revue neurologique 20060301
Title: [Pathophysiology and treatment of fatigue in multiple sclerosis].
Journal: Revue neurologique 20060301
Title: NCAM 180 acting via a conserved C-terminal domain and MLCK is essential for effective transmission with repetitive stimulation.
Journal: Neuron 20050616
Title: Taicatoxin inhibits the calcium-dependent slow motility of mammalian outer hair cells.
Journal: Hearing research 20050501
Title: Treatment for Lambert-Eaton myasthenic syndrome.
Journal: The Cochrane database of systematic reviews 20050418
Title: Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
Journal: Annals of the New York Academy of Sciences 20050401
Title: Cognitive deficits in aged rats correlate with levels of L-arginine, not with nNOS expression or 3,4-DAP-evoked transmitter release in the frontoparietal cortex.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050301
Title: Electrophysiological and pharmacological characterization of K+-currents in muscle fibres isolated from the ventral sucker of Fasciola hepatica.
Journal: Parasitology 20041201
Title: Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries.
Journal: Hypertension (Dallas, Tex. : 1979) 20040901
Title: Upbeat about downbeat nystagmus.
Journal: Neurology 20040824
Title: Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus.
Journal: Neurology 20040824
Title: Determination of A 3,4-diaminopyridine in plasma by liquid chromatography with electrochemical detection using solid-phase extraction.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040615
Title: Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine.
Journal: Neurology 20040608
Title: Distinct phenotypes of congenital acetylcholine receptor deficiency.
Journal: Neuromuscular disorders : NMD 20040601
Title: Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage.
Journal: Journal of neurology, neurosurgery, and psychiatry 20040601
Title: Cure of experimental botulism and antibotulismic effect of toosendanin.
Journal: Acta pharmacologica Sinica 20040601
Title: Combination of variable frequency train stimulation and K+ channel blockade to augment skeletal muscle force.
Journal: IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 20040601
Title: Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation.
Journal: Pharmacology, biochemistry, and behavior 20040301
Title: Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
Journal: Neuromuscular disorders : NMD 20040301
Title: Lambert-Eaton myasthenic syndrome.
Journal: Revue neurologique 20040201
Title: 3,4-DAP-evoked transmitter release in hippocampal slices of aged rats with impaired memory.
Journal: Brain research bulletin 20031215
Title: [Formulation and stability of hospital preparation of 3,4-diaminopyridine capsules].
Journal: Annales pharmaceutiques francaises 20031101
Title: Sternohyoid muscle fatigue properties of dy/dy dystrophic mice, an animal model of merosin-deficient congenital muscular dystrophy.
Journal: Pediatric research 20031001
Title: Lambert-eaton myasthenic syndrome: diagnosis and treatment.
Journal: Annals of the New York Academy of Sciences 20030901
Title: Wheel-running exercise alters rat diaphragm action potentials and their regulation by K+ channels.
Journal: Journal of applied physiology (Bethesda, Md. : 1985) 20030801
Title: Potassium channels, the cerebellum, and treatment for downbeat nystagmus.
Journal: Neurology 20030722
Title: Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
Journal: Neurology 20030722
Title: Rational modelling of the voltage-dependent K+ channel inactivation by aminopyridines.
Journal: Biophysical chemistry 20030601
Title: Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Journal: Seminars in neurology 20030601
Title: The vascular response to the K+ channel inhibitor 4-aminopyridine in hypertensive rats.
Journal: European journal of pharmacology 20030418
Title: Streptozotocin-diabetes alters action potentials in rat diaphragm.
Journal: Respiratory physiology & neurobiology 20030415
Title: Quantitative estimate of mitochondrial [Ca2+] in stimulated motor nerve terminals.
Journal: Cell calcium 20030301
Title: Membrane properties related to the firing behavior of zebrafish motoneurons.
Journal: Journal of neurophysiology 20030201
Title: Exacerbation of Lambert-Eaton myasthenic syndrome caused by an L-type Ca2+ channel antagonist.
Journal: Japanese heart journal 20030101
Title: Treatment for Lambert-Eaton myasthenic syndrome.
Journal: The Cochrane database of systematic reviews 20030101
Title: Effect of thymol on kinetic properties of Ca and K currents in rat skeletal muscle.
Journal: BMC pharmacology 20030101
Title: Raphé grafts and 3,4-diaminopyridine-evoked overflow of serotonin in the rat hippocampus after 5,7-dihydroxytryptamine lesions: evidence for 5-HT1A autoreceptors.
Journal: Neuroreport 20021028
Title: Analysis of the pressor response to the K+ channel inhibitor 4-aminopyridine.
Journal: European journal of pharmacology 20021011
Title: Preparation of 3,4-diaminopyridine microparticles by solvent-evaporation methods.
Journal: International journal of pharmaceutics 20020821
Title: Improvement of dy/dy dystrophic diaphragm by 3,4-diaminopyridine.
Journal: Muscle & nerve 20020701
Title: The nature of the receptor site for the reversible K+ channel blocking by aminopyridines.
Journal: Biophysical chemistry 20020410
Title: [Treatment of severe botulism with 3,4-diaminopyridine]].
Journal: Presse medicale (Paris, France : 1983) 20020406
Title: Potassium channel KV alpha1 subunit expression and function in human detrusor muscle.
Journal: The Journal of urology 20020401
Title: Action of Micrurus dumerilii carinicauda coral snake venom on the mammalian neuromuscular junction.
Journal: Toxicon : official journal of the International Society on Toxinology 20020201
Title: Activation thresholds of K(V), BK andCl(Ca) channels in smooth muscle cells in pial precapillary arterioles.
Journal: Journal of vascular research 20020101
Title: Role of K+ channels in L-6 myoblast migration.
Journal: Journal of muscle research and cell motility 20020101
Title: Aminopyridines for symptomatic treatment in multiple sclerosis.
Journal: The Cochrane database of systematic reviews 20020101
Title: [Lambert-Eaton myasthenic syndrome: diagnosis and treatment].
Journal: Clinical calcium 20011101
Title: Expression and function of native potassium channel [K(V)alpha1] subunits in terminal arterioles of rabbit.
Journal: The Journal of physiology 20010801
Title: [Quantitative evaluation of the effect of 3,4-diaminopyridine in a patient with Lambert-Eaton myasthenic syndrome using dynamic dynamometry].
Journal: Rinsho shinkeigaku = Clinical neurology 20010801
Title: Theoretical analysis of the molecular determinants responsible for the K(+) channel blocking by aminopyridines.
Journal: Biophysical chemistry 20010615
Title: Neuromuscular monitoring in myasthenic syndrome.
Journal: Anaesthesia 20010601
Title: Electrophysiological analysis of the neurotoxic action of a funnel-web spider toxin, delta-atracotoxin-HV1a, on insect voltage-gated Na+ channels.
Journal: The Journal of experimental biology 20010201
Title: Modulation of diaphragm action potentials by K(+) channel blockers.
Journal: Respiration physiology 20010201
Title: Validation of a CE assay for the analysis of isomeric aminopyridines and diaminopyridines.
Journal: Journal of pharmaceutical and biomedical analysis 20010201
Title: Neurogenic bladder in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine.
Journal: Journal of the neurological sciences 20010115
Title: [Proximal muscle weakness, depressed tendon reflexes and autonomic dysfunction: the Lambert-Eaton myasthenic syndrome].
Journal: Nederlands tijdschrift voor geneeskunde 20010113
Title: Development and validation of a capillary electrophoresis assay for the determination of 3,4-diaminopyridine and 4-aminopyridine including related substances.
Journal: Journal of chromatography. A 20010112
Title: Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
Journal: Toxicon : official journal of the International Society on Toxinology 20010101
Title: Aminopyridines for symptomatic treatment in multiple sclerosis.
Journal: The Cochrane database of systematic reviews 20010101
Title: Antagonism of botulinum toxin A-mediated muscle paralysis by 3, 4-diaminopyridine delivered via osmotic minipumps.
Journal: Toxicon : official journal of the International Society on Toxinology 20001001
Title: Antagonism of botulinum toxin-induced muscle weakness by 3,4-diaminopyridine in rat phrenic nerve-hemidiaphragm preparations.
Journal: Toxicon : official journal of the International Society on Toxinology 19950401
Title: Maarten J Titulaer, et al. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011 Dec;10(12):1098-107.
Title: T L Harris, et al. Lycopodium clavatum exine microcapsules enable safe oral delivery of 3,4-diaminopyridine for treatment of botulinum neurotoxin A intoxication. Chem Commun (Camb). 2016 Mar 18;52(22):4187-90.
